Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Belin

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trialL Belin, M Kamal, C Mauborgne, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Prognosis of glioblastoma patients improves significantly over time interrogating historical controlsA Thomas-Joulié, S Tran, L El Houari, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trialL Belin, M Kamal, C Mauborgne, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2024
Prognosis of glioblastoma patients improves significantly over time interrogating historical controlsA Thomas-Joulié, S Tran, L El Houari, et al.
Pageof 9